CRP is a cardio-biomarker which can assess risk for future heart attacks

Menlo Park, CA — LamdaGen Corporation presented data on its work for the visual POC (Point of Care) detection of CRP (C-reactive protein), an important cardio-biomarker that can assess risk for future heart attacks, at the American Association of Clinical Chemists’ Oakridge Conference held in San Jose, California, on April 17 and 18, 2008.

The poster, “Enhanced Localized Surface Plasmon Resonance (E-LSPR) as a novel detection method for IVD tests”, authored by Huber, M. and Gerion, D., Menlo Park, CA., was presented to Oakridge Conference attendees. The data focused on the detection of CRP via LamdaGen’s E-LSPR technology coupled with its OES biosensor, which is able to detect CRP concentrations of less than 1.0 mg/L in patients’ whole blood. The OES biosensor, amplified with antibodies on its surface, is a highly sensitive, fast and visual POC diagnostic that can be monitored by the naked-eye. There is no need for expensive and bulky instrumentation.

LamdaGen Corporation is a privately funded California-based developer of proprietary optical biosensors. LamdaGen’s mission is to become a leading supplier of state-of-the-art detections systems incorporating new advances in bio-sensing based upon nano-structured surfaces. The Company is commercializing its advanced sensors and instruments using its patented technology to enhance real-time, label-free detection and analysis of biomolecules across several large markets and industries. LamdaGen’s technologies have been developed for use in medical diagnostics, bioresearch, drug discovery and development, and mid-to-high throughput screening of proteins.

About AACC:

AACC is an international scientific / medical society dedicated to improving healthcare through laboratory medicine. Its nearly 10,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations. AACC brings this community together with programs that advance knowledge, expertise, and innovation. AACC is best known for the respected scientific journal Clinical Chemistry, the award-winning patient-centered web site Lab Tests Online, and the world’s largest conference on laboratory medicine and technology. Through these and other programs, AACC advances laboratory medicine and the quality of patient care. For more information, see

For more information regarding LamdaGen Corporation, please visit